论文信息 - Brief Report: Effective treatment of lung adenocarcinoma harboring EGFR-activating mutation/T790M/cis-C797S triple mutations by brigatinib and cetuximab combination therapy. - 字舞流文

Brief Report: Effective treatment of lung adenocarcinoma harboring EGFR-activating mutation/T790M/cis-C797S triple mutations by brigatinib and cetuximab combination therapy.

N. Yang | Yongchang Zhang | Yong He | A. Lizaso | Li Li | Yubo Wang | Mengxiao Zhu | Rui Han | T. Qin | Hengyi Chen | F. Xia | Xiaoyan Liu | Fengming Xia | R. Han